Power Law company profile

Audentes Therapeutics

Biotech & Life Sciences · San Francisco, United States · Founded 2013 · IPO 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Investors

12 investors on Audentes Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

5AM Ventures

OrbiMed

Versant Ventures

Series B+ 9 investors entered at this stage

Cormorant Asset Management

Asset Management Ventures

Deerfield

Redmile Group

Venrock

RA Capital Management

Rock Springs Capital

Sofinnova Investments

Foresite Capital

Patent intelligence

$4M patent portfolio · 7 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value

$4M

607× smaller than top peer Illumina ($2.7B)

7 active patent families

Where Audentes Therapeutics innovates Myotubular MyopathyMyopathyCombination therapyNeuroscienceLiver function

Tech-focus vs peers

Where Audentes Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Audentes Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Audentes Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo